TriSalus Life Sciences, Inc.
General ticker "TLSI" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $148.5M (TTM average)
TriSalus Life Sciences, Inc. does not follow the US Stock Market performance with the rate: -2.1%.
Estimated limits based on current volatility of 4.4%: low 6.74$, high 7.36$
Factors to consider:
- Total employees count: 110 as of 2024
- Current price 22.7% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.03$, 6.11$]
- 2025-12-31 to 2026-12-31 estimated range: [2.07$, 5.98$]
Financial Metrics affecting the TLSI estimates:
- Positive: with PPE of -3.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -34.60 <= 0.33
- Negative: Shareholder equity ratio, % of -108.02 <= 18.93
- Positive: Interest expense per share per price, % of 2.62 <= 3.41
- Positive: Inventory ratio change, % of 0 <= 0.84
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of -0.29 > -0.66
- Positive: Return on assets ratio (scaled to [-100,100]) of 55.62 > 6.04
Short-term TLSI quotes
Long-term TLSI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $12.40MM | $18.51MM | $29.43MM |
| Operating Expenses | $48.84MM | $72.99MM | $65.60MM |
| Operating Income | $-36.44MM | $-54.48MM | $-36.16MM |
| Non-Operating Income | $-10.74MM | $-4.88MM | $6.13MM |
| Interest Expense | $0.00MM | $0.02MM | $3.09MM |
| R&D Expense | $21.36MM | $29.84MM | $17.69MM |
| Income(Loss) | $-47.18MM | $-59.35MM | $-30.04MM |
| Taxes | $0.01MM | $0.01MM | $-0.01MM |
| Profit(Loss)* | $-47.19MM | $-59.36MM | $-33.23MM |
| Stockholders Equity | $-12.32MM | $-27.07MM | $-25.89MM |
| Inventory | $1.47MM | $2.54MM | $4.05MM |
| Assets | $22.00MM | $24.60MM | $23.97MM |
| Operating Cash Flow | $-32.31MM | $-50.58MM | $-40.84MM |
| Capital expenditure | $0.79MM | $0.59MM | $0.34MM |
| Investing Cash Flow | $-1.79MM | $-1.59MM | $-0.34MM |
| Financing Cash Flow | $13.46MM | $54.63MM | $37.94MM |
| Earnings Per Share** | $-1.59 | $-2.24 | $-1.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.